2001 – today
German Chancellor Gerhard Schröder officially opens "Plant 2001" for filter production in Goettingen. This plant is the then largest single investment ever made in Sartorius’ corporate history. Also, Sartorius College, a conference center promoting the internal and external transfer of knowledge, is inaugurated in a festive ceremony (photo).
With the GENIUS analytical balance, Sartorius AG wins the Innovation Award of the German Economy in the category of medium-sized companies.
A new Sartorius Knowledge Center is inaugurated in Bangalore, India. The "Combics" modular series of industrial scales and related equipment is launched.
Sartorius receives the Initiative Prize for Training and Continuing Education from the Otto Wolff Foundation, the German Chamber of Commerce and Industry and from the "WirtschaftsWoche", a German-language weekly financial journal.
Brands are integrated and new names are created for Group member companies:
- Sartorius Aachen GmbH & Co. KG (formerly Boekels)
- Sartorius Hamburg GmbH (formerly GWT)
- Sartorius BBI Systems GmbH (formerly B. Braun Biotech International)
Sartorius receives the renowned Frost & Sullivan Award for outstanding innovation in biotech product differentiation.
A.T. Kearney, a global management consultancy, and "WirtschaftsWoche", a German weekly business news magazine, honor Sartorius as the "Best Innovator in 2005" in the Time-to-Profit category.
Sartorius buys a 100% stake in application specialist Omnimark Instrument Corporation based in Arizona, USA.
The international consulting company "Frost & Sullivan" confers the "2006 Growth Strategy Leadership Award" to Sartorius for its successful market segment of moisture analyzers.
Sartorius combines its Biotechnology Division with the French-based biotech supplier Stedim S.A. to enable their joint company Sartorius Stedim Biotech to become a leading international technology provider to the biopharmaceutical industry. The new company is listed on the Paris Euronext Stock Exchange. Official groundbreaking ceremony for a new plant in Beijing. Sartorius has now doubled its production capacity in China from roughly a former 4,000 square meters to more than 8,000 square meters (photo). Sartorius acquires Toha Plast GmbH and strengthens its position in plastics technology for biopharmaceutical disposables. Official groundbreaking ceremony for a new laboratory building: This enables Sartorius to continue expanding R&D capacities for the Biotechnology Division at its Goettingen headquarters.
With new subsidiaries in Poznan, Poland, and in Budapest, Hungary, both company divisions strengthen their sales and distribution operations in Eastern Europe.
Sartorius Stedim Biotech extends its product portfolio for viral safety in the manufacture of biopharmaceuticals by forming an alliance with Bayer Technology Services.
Sartorius Stedim Biotech GmbH acquires Swiss-based Wave Biotech AG, a leading supplier of single-use bioreactors.
The Mechatronics and Biotechnology Division of Sartorius holds inauguration ceremonies for its Sartorius India Campus in Bangalore with a floor area of 10,000 square meters (photo).
A new factory is opened in Arvada, Colorado: Sartorius extends available capacity and now has a total area of some 6,000 square meters (nearly 65,000 square feet).
Sartorius signs a cooperation agreement with Metrohm Schweiz AG for marketing Sartorius Mechatronics laboratory equipment in Switzerland.
Sartorius signs cooperation agreements with four companies, thereby expanding its product offering:
- Co-marketing alliance with Corning: A mutual product catalogue is published on equipment and disposables for cell culture applications in the lab.
- Alliance with TEWS Elektronik: Agreement signed for exclusive marketing and servicing of microwave resonance analyzers by Sartorius.
- Alliance with Schmidt+Haentsch: Sartorius markets the Brixxus series of laboratory refractometers.
- Alliance with NIR Online: Sartorius is granted the right to sell and service near infrared spectroscopy systems for customers in the food and pharmaceutical industries
The legal corporate structure of Sartorius AG is transformed into a holding company organization: The Annual Shareholders’ Meeting resolves to run the operational mechatronics business, conducted so far within Sartorius AG, as an independent entity below the holding level. This move further enhances the company’s ability to generate dividends and increases the transparency of its corporate structure.
Sartorius acquires the liquid handling segment of Biohit, the Finnish laboratory specialist (photo). The Group thus adds a key component to its product offering for laboratory instruments.
In January 2012, Sartorius conducts its business operations in three new divisions: Bioprocess Solutions, Lab Products & Services and Industrial Weighing. These new divisions each combine their respective businesses for the same customer groups and fields of application and thus more clearly reflect Sartorius’ focus on its major markets.
Sartorius relocates its single-use bag manufacture from California to Puerto Rico; covering an area of 5,000 square meters, or 53,820 square feet, the new eco-friendly building complex for manufacturing filters and aseptic bags is officially opened (photo).
At its headquarters in Goettingen, Germany, Sartorius formally opens a new building with a floor space of 6,000 square meters, or nearly 65,000 square feet, for membrane manufacture.
The company officially opens a new production facility with a floor space of around 9,000 square meters, or of nearly 100,000 square feet, in Guxhagen, Germany, for bioreactors.
Sartorius expands its bioprocess portfolio by adding cell culture media: the company signs a long-term collaboration, supply and distribution agreement with the Swiss-based life science group Lonza.
Sartorius moves up to the TecDAX, the leading index of the 30 largest and most liquid German technology stocks.
Just after approximately one year of construction, the new building with a floor space of 2,700 square meters, or 29,063 square feet, in Goettingen is officially opened for injection molding manufacture of plastic components.
Sartorius acquires the UK company TAP Biosystems Group plc through its subgroup Sartorius Stedim Biotech; this acquisition further expands Sartorius’ bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development.
Shanghai becomes home to the new Asian sales and marketing headquarters of the Sartorius Group that manages all sales and marketing activities for China and for the entire Asian region.
Together with its partner Zufall Logistics, Sartorius opens a new logistics center at the Siekanger distribution zone in Goettingen, Germany. From this center, laboratory and process products are shipped out worldwide and all Goettingen-based Sartorius sites are supplied (photo).
Sartorius, through its subgroup Sartorius Stedim Biotech, acquires the majority stake in the U.S. startup AllPure Technologies LLC; the AllPure product range complements Sartorius’ single-use-portfolio for the biopharmaceutical industry.
In Shanghai, China, Sartorius opens a new application center featuring the most advanced laboratory facilities and equipment for product tests, demonstrations and training sessions. As a result, the company is strengthening its position on the Asian market.
The Industrial Technologies Division specializing in industrial weighing and control equipment is sold to the Japanese group Minebea Co., Ltd. This now enables Sartorius to focus on its core bioprocess and lab businesses.
Sartorius acquires the companies Bio-Outsource based in Glasgow, Scotland and Cellca based in Laupheim, Germany. Both acquisitions complement the process development portfolio.
In Bohemia, NY Sartorius opens a new application center for the Americas featuring the most advanced laboratory facilities and equipment for product tests, demonstrations and training sessions.
Sartorius acquires the companies IntelliCyt and ViroCyt, both based in the USA, to expand the portfolio of its Lab Products & Services Division into bioanalytics. With the acquisition of centrifuge specialist kSep Systems, also headquartered in the USA, Sartorius adds another innovative single-use technology to its bioprocessing product array.
In Stonehouse, UK Sartorius expands its site, doubling its local production capacities for single-use plastic products for laboratories.
On the Sartorius Campus in Goettingen production starts at the new building for the manufacture of lab instruments.
Sartorius is continuing to expand the bioanalytics portfolio of its Laboratory Products & Services Division by acquiring Essen BioScience. This U.S. company is an innovation leader in cell analysis systems for medical drug research.